Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives

被引:9
|
作者
Aghaei-Zarch, Seyed Mohsen [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Med, Dept Med Genet, Tehran, Iran
来源
NON-CODING RNA RESEARCH | 2024年 / 9卷 / 02期
关键词
Diabetes mellitus; PI3K/AKT; miRNA; lncRNA; PROMOTES INSULIN-RESISTANCE; ENDOTHELIAL-CELL; MESENCHYMAL TRANSITION; GLUCOSE-METABOLISM; OXIDATIVE STRESS; RAT MODEL; RETINOPATHY; RNA; PROLIFERATION; NEPHROPATHY;
D O I
10.1016/j.ncrna.2024.01.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes as a fastest growing diseases worldwide is characterized by elevated blood glucose levels. There's an enormous financial burden associated with this endocrine disorder, with unequal access to health care between developed and developing countries. PI3Ks (phosphoinositide 3-kinases) have been demonstrated to be crucial for glucose homeostasis, and malfunctioning of these molecules can contribute to an increase in glucose serum levels, the main pathophysiological feature of diabetes. Additionally, recent evidence suggests that miRNAs and lncRNAs are reciprocally interacting with this signaling pathway. It is therefore evident that abnormal regulation of miRNAs/lncRNAs in the lncRNAs/miRNAs/PI3K/AKT axis is related to clinicopathological characteristics and plays a crucial role in the regulation of biological processes. It has therefore been attempted in this review to describe the interaction between PI3K/AKT signaling pathway and various miRNAs/lncRNAs and their importance in DM biology. We also presented the clinical applications of PI3K/AKT-related ncRNAs/herbal medicine in patients with DM.
引用
收藏
页码:486 / 507
页数:22
相关论文
共 50 条
  • [1] Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
    Chen Xue
    Ganglei Li
    Juan Lu
    Lanjuan Li
    Signal Transduction and Targeted Therapy, 6
  • [2] Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
    Xue, Chen
    Li, Ganglei
    Lu, Juan
    Li, Lanjuan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [3] Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
    Akbarzadeh, Maryam
    Mihanfar, Ainaz
    Akbarzadeh, Shabnam
    Yousefi, Bahman
    Majidinia, Maryam
    LIFE SCIENCES, 2021, 285
  • [4] Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review)
    Zhang, Xiaoyu
    Shi, Lei
    Xing, Mengzhen
    Li, Chunjing
    Ma, Fengjun
    Ma, Yuning
    Ma, Yuxia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2025, 55 (01)
  • [5] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [6] 'Investigation of miRNAs That Affect the PI3K/AKT/mTOR Signaling Pathway in Endometrial Cancer'
    Oz, Hasan
    Canacankatan, Necmiye
    Antmen, Serife Efsun
    Aytan, Hakan
    Tuncel, Ferah
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2025,
  • [7] Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer
    Rahmani, Farzad
    Ferns, Gordon A.
    Talebian, Sahar
    Nourbakhsh, Mahnaz
    Avan, Amir
    Shahidsales, Soodabeh
    GENE, 2020, 737
  • [8] Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium
    Hsu, Alice H.
    Lum, Michelle A.
    Shim, Kang-Sup
    Frederick, Peter J.
    Morrison, Carl D.
    Chen, Baojiang
    Lele, Subodh M.
    Sheinin, Yuri M.
    Daikoku, Takiko
    Dey, Sudhansu K.
    Leone, Gustavo
    Black, Adrian R.
    Black, Jennifer D.
    CELL REPORTS, 2018, 24 (03): : 655 - 669
  • [9] PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
    Guo, Ningning
    Wang, Xin
    Xu, Muran
    Bai, Jie
    Yu, Hao
    Zhang, Le
    PHARMACOLOGICAL RESEARCH, 2024, 206
  • [10] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078